BONEX logo

Bonesupport Holding Stock Price

Symbol: OM:BONEXMarket Cap: SEK 20.8bCategory: Pharmaceuticals & Biotech

BONEX Share Price Performance

SEK 315.80
45.60 (16.88%)
25.0% undervalued intrinsic discount
SEK 421.20
Fair Value
SEK 315.80
45.60 (16.88%)
25.0% undervalued intrinsic discount
SEK 421.20
Fair Value
Price SEK 315.80
AnalystConsensusTarget SEK 421.20

BONEX Community Narratives

AN
AnalystConsensusTarget
AnalystConsensusTarget·Updated
Fair Value SEK 421.20 25.0% undervalued intrinsic discount

FDA Submission And US Launch Will Drive Success

0users have liked this narrative
0users have commented on this narrative
17users have followed this narrative

Recent BONEX News & Updates

No updates

Bonesupport Holding AB (publ) Key Details

SEK 1.1b

Revenue

SEK 78.7m

Cost of Revenue

SEK 983.8m

Gross Profit

SEK 835.8m

Other Expenses

SEK 148.0m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Oct 23, 2025
Earnings per share (EPS)
2.25
Gross Margin
92.59%
Net Profit Margin
13.93%
Debt/Equity Ratio
0%

Bonesupport Holding AB (publ) Competitors

 
 
 
 
 
 
 
 
 
 
 
 

About BONEX

Founded
1999
Employees
140
CEO
Emil Billbäck
WebsiteView website
www.bonesupport.com

Bonesupport Holding AB (publ), an orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally. The company provides CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin during the critical first 30 days of bone healing, as well as treats and prevents bone infection; CERAMENT V, an injectable ceramic bone graft substitute that remodels to host bone and elutes Vancomycin during the critical first 30 days of bone healing, as well as treats and prevents bone infection. It also offers CERAMENT Bead Tray, an adjunctive local delivery option for surgeons for targeted delivery to osseous defects and for dead space management. In addition, the company develops preclinical product candidates to promote bone regrowth focusing on trauma, revision arthroplasty, chronic osteomyelitis, and foot and ankle surgery. Bonesupport Holding AB (publ) was founded in 1999 and is headquartered in Lund, Sweden.

Swedish Market Performance

  • 7 Days: 0.6%
  • 3 Months: 3.8%
  • 1 Year: 2.5%
  • Year to Date: 0.7%
Over the last 7 days, the market has dropped 1.5%, driven by a decline of 2.3% in the Industrials sector. Overall the market has been flat in the last year. Earnings are forecast to grow by 17% annually. Market details ›
This week, we are weighing up the potential productivity gains vs job losses and economic disruption that the global economy could face over the next decade and beyond.
Continue reading